| View |
|
DR-XY31582
|
Chloramphenicol
|
Chloro-V
|
5 mg/mL (0.5%)
|
Otic Solution (Drops)
|
Anti-infective
|
EL Laboratories, Inc
|
Philippines
|
Renewal
|
18 August 2022
|
02 August 2027
|
| View |
|
DR-XY31588
|
Piracetam
|
Iracet
|
400 mg
|
Capsule
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
15 April 2021
|
07 April 2026
|
| View |
|
DR-XY31600
|
Fluconazole
|
Flucoral
|
150 mg
|
Capsule
|
Antifungal
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
21 April 2021
|
07 April 2026
|
| View |
DR-XY31603_PI_01.pdf
|
DR-XY31603
|
Gadobutrol
|
Gadovist
|
1mmol/Ml
|
Solution for Injection (IV)
|
Paramagnetic Contrast Media
|
Bayer Pharma AG
|
Germany
|
Automatic Renewal
|
20 April 2023
|
22 May 2028
|
| View |
|
DR-XY31605
|
Cefaclor (as monohydrate)
|
Cloran
|
125mg/5mL
|
Powder For Suspension
|
Antibacterials (Cephalosporins)
|
Scheele Laboratories Phil. Inc
|
Philippines
|
Automatic Renewal
|
15 December 2022
|
10 April 2028
|
| View |
|
DR-XY31621
|
Pyrantel (As Pamoate)
|
Pyped
|
250 mg / 5 mL
|
Suspension
|
Anthelmintic
|
Drugmakers Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
05 January 2023
|
12 April 2028
|
| View |
|
DR-XY31634
|
Paracetamol
|
Anaseran
|
100 mg/mL
|
Suspension (Oral Drops)
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
11 May 2018
|
18 April 2026
|
| View |
|
DR-XY31646
|
Cefaclor (As Monohydrate)
|
None
|
500 MG
|
Capsule
|
Antibacterials (Cephalosporins)
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
13 February 2023
|
18 April 2028
|
| View |
|
DR-XY31651
|
Cefuroxime (as axetil )
|
C-Tri T
|
250mg
|
Film Coated Tablet
|
Antibacterial (Cephalosporin)
|
Emcure Pharmaceuticals Limited
|
India
|
Automatic Renewal
|
30 April 2021
|
19 April 2026
|
| View |
|
DR-XY31673
|
Hydrocortisone (as Sodium Succinate)
|
Stericort
|
500 mg
|
Powder For Injection (I.V./I.M.)
|
Corticosteroid
|
Karnataka Antibiotics & Pharmaceuticals Limited
|
India
|
Renewal
|
10 May 2024
|
02 May 2029
|
| View |
|
DR-XY31687
|
Cefuroxime (as Axetil)
|
C-Tri-T
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Emcure Pharmaceuticals Limited
|
India
|
Automatic Renewal (Reconstruction)
|
18 June 2024
|
03 March 2026
|
| View |
|
DR-XY31691
|
Cefaclor
|
Unbranded
|
250 mg / 5 mL
|
Powder For Suspension
|
Antibacterials (Cephalosporins)
|
Drugmaker's Laboratories Inc.
|
Philippines
|
Renewal
|
13 March 2023
|
04 May 2028
|
| View |
|
DR-XY31692
|
Cefaclor (As Monohydrate)
|
Cloran
|
250mg/5mL
|
Powder For Suspension
|
-
|
Scheele Laboratories Phils., Inc.
|
Philippines
|
-
|
21 May 2021
|
04 May 2026
|
| View |
|
DR-XY31693
|
Multivitamins
|
Beetab
|
Each tablet contains:
Thiamine Mononitrate (Vitamin B1)-100mg Pyridoxine Hydrochloride (Vitamin B6)-50mg Cyanocobalamin (Vitamin B12)-100mcg d-Alpha Tocopheryl Acetate (Vitamin E)-50IU
|
Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
08 April 2021
|
25 May 2026
|
| View |
|
DR-XY31704
|
Cetirizine Dihydrochloride
|
Allerkid
|
5 mg/5 mL
|
Syrup (Grape Flavor)
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
13 April 2020
|
12 July 2025
|
| View |
|
DR-XY31705
|
Pioglitazone Hydrochloride
|
None
|
15 mg
|
Tablet
|
Oral Hypoglycemic (Thiazolidinedione)
|
USV Private Limited
|
India
|
Automatic Renewal
|
04 May 2021
|
28 June 2026
|
| View |
|
DR-XY31725
|
Sangobion Iron+
|
Multivitamins + Minerals
|
Each capsule contains: Ascorbic Acid (Vitamin C)-50mg Folic Acid (Vitamin B9)-1mg Cyanocobalamin (Vitamin B12)-7.5mcg Iron (equivalent to 250mg Ferrous Gluconate) -30mg
Manganese Sulfate-200mcg
Copper Sulfate-200mcg
|
Capsule
|
-
|
PT. Merck TBK
|
Indonesia
|
-
|
14 May 2021
|
11 May 2026
|
| View |
|
DR-XY31729
|
Cetirizine Dihydrochloride
|
Allerkid
|
2.5 mg/mL
|
Syrup (Oral Drops)
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
01 April 2020
|
06 April 2025
|
| View |
|
DR-XY31745
|
Ravenar
|
Simvastatin
|
20 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
20 May 2021
|
22 May 2026
|
| View |
|
DR-XY31760
|
Solifenacin succinate
|
Vesicare
|
10mg
|
Film-coated tablet
|
Muscarinic Receptor Antagonist
|
Astellas Pharma Europe B.V.
|
Netherlands
|
Renewal
|
12 October 2024
|
10 October 2029
|